Full Text
Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog

Abstract

Authors

CA Bly JC Gahn RC Wielage RW Klein K Brown S Kalirai

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×